Lung Cancer

Published by: Elsevier Ireland Ltd.  

People

  1. Kris
    Kris
  2. Rusch
    Rusch
  3. Ginsberg
    Ginsberg
  4. Cheung
    Cheung
  5. Cheung
    Cheung
  6. Holodny
    Holodny
  7. Ladanyi
    Ladanyi
  8. Ng
    Ng
  9. Seshan
    Seshan
  10. Travis
    Travis

Groups

  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (8)
  4. Body Imaging Service (6)
  5. Radiology, Department of (6)
  6. Surgery (6)
  7. GSK Faculty (5)
  8. Tow Center for Developmental Oncology (TCDO) (4)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  10. Center for Pancreatic Cancer Research (3)
Search Within
  1. "Lee Krug"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (7)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (8)
  4. Body Imaging Service (6)
  5. Radiology, Department of (6)
  6. Surgery (6)

More Groups

People
  1. Lee Krug (18)
  2. Mark Kris (7)
  3. Valerie Rusch (6)
  4. Michelle Ginsberg (4)
  5. Camelia Sima (3)
  6. Kenneth Rosenzweig (3)

More People

Years
  1. 2016 (1)
  2. 2014 (3)
  3. 2011 (1)
  4. 2010 (1)
  5. 2006 (6)
  6. 2005 (5)

More Years

Publishers
  1. Elsevier Ireland Ltd. (18)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
    Journal Article

    Pietanza, M. C.; Litvak, A. M.; Varghese, A. M.; Krug, L. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A. I.; Sima, C. S.; Woo, K. M.; Ng, K. K.; more...
    Lung Cancer (2016)

    Fulltext@MSK | Save
  • Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase
    Journal Article

    Zauderer, M. G.; Drilon, A.; Kadota, K.; Huberman, K.; Sima, C. S.; Bergagnini, I.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; more...
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma
    Journal Article

    Krug, L. M.; Wozniak, A. J.; Kindler, H. L.; Feld, R.; Koczywas, M.; Morero, J. L.; Rodriguez, C. P.; Ross, H. J.; Bauman, J. E.; Orlov, S. V.; more...
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Kass, S. L.; Woo, K.; Sima, C. S.; Ginsberg, M. S.; Krug, L. M.
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
    Journal Article

    Paik, P. K.; Rudin, C. M.; Pietanza, M. C.; Brown, A.; Rizvi, N. A.; Takebe, N.; Travis, W.; James, L.; Ginsberg, M. S.; Juergens, R.; more...
    Lung Cancer (2011)

    Fulltext@MSK | Save
  • Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer
    Journal Article

    Chen, L.; Brown, A. B.; Cheung, I. Y.; Cheung, N. K. V.; Kris, M. G.; Krug, L. M.
    Lung Cancer (2010)

    Fulltext@MSK | Save
  • Development of a computer method for volumetric response assessment in mesothelioma
    Meeting Abstract

    Zhao, B.; Schwartz, L.; Liu, F.; Wang, L.; Krug, L.; Flores, R.; Rusch, V.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • An integrated genomic approach to understanding the determinants of mesotheliorna sensitivity to specific novel agents
    Meeting Abstract

    Shimizu, S.; Olshen, A. B.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • MET in mesothelioma: Mutational screening, phosphorylation status, and sensitivity to the MET inhibitor PHA-665752
    Meeting Abstract

    Shimizu, S.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (FIT) for malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Pass, H. I.; Rusch, V. W.; Kindler, H. L.; Sugarbaker, D. J.; Rosenzweig, K. E.; Friedberg, J. S.; Raman, J.; Ye, Z.; Obasaju, C.; more...
    Lung Cancer (2006)

    Fulltext@MSK | Save

    • Lung Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Inc.
    Lung Cancer 0169-5002 Elsevier Inc.
    Lung Cancer 01695002 Elsevier Science Ireland Ltd
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 2019
    Lung Cancer 01695002 1995
    Lung Cancer 0169-5002 Elsevier Sci Publ Ireland Ltd
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 1993
    Lung Cancer 0169-5002 Elsevier Science, Inc.
    Lung Cancer 18728332 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier B.V.
    Lung Cancer 1872-8332 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 1695002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Unknown
    Lung Cancer 01695002 The Author(s)
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 Unknown
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 2017
    Lung Cancer 01695002 Elsevier B.V.
    Lung Cancer 01695002 2018
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung cancer (Amsterdam, Netherlands) 01695002 Unknown